LifeSpring is the leading Dutch life science public relations agency dedicated to supporting Dutch and International companies that are advancing biotechnology, genomics, bioinformatics, molecular diagnostics, and molecular and synthetic biology. LifeSpring serves innovation makers, those who go beyond medical and scientific discoveries to where innovation adds life-changing value. Track record: Biotech, Medtech, Diagnostics: Agendia, Amarna Therapeutics, AM Pharma, A-Skin, Cristal Therapeutics, CytuVax, Elekta, Esperite (formerly CryoSave), Fornix BioSciences, Galapagos, Genmab, IME Technologies, Lead Pharma, MDxHealth, Mellon Medical, Mimetas, Modra Pharmaceuticals, Nevro, Noxxon Pharma, Pharming Group, Polyganics, Prosensa (BioMarin), SkylineDX, Sigma Screening, Synthon Biopharmaceuticals, 2-BBB, uniQure (AMT), VarmX. Healthcare and Biotech Venture Capital: Aglaia BioMedical Ventures, BioGeneration Ventures, Forbion Capital Partners, LSP, Van Herk Group, Holland Venture and DDF Ventures (and its related companies). Leon Melens founded LifeSpring late 2015, after having built a vast life science practice as a partner of leading Dutch financial and IR agency SPJ over the previous sixteen years. A period in which Dutch biotech has started to play a serious role within the world wide life sciences industry. LifeSpring has a nice and proven track record ranging from well known biotechs to promising early stage ventures and biotech VC's. Work ranges from IPO's, financial PR, media relations, story telling, brand building, building online strategies and content marketing. LifeSpring works with a number of London based life sciences communications agencies like Instinctif Partners, Consilium and FTI.